In recent times, the UK market has faced challenges, with the FTSE 100 experiencing declines due to weak trade data from China and global economic uncertainties. In such a climate, dividend stocks can offer a measure of stability and income potential for investors looking to enhance their portfolios amidst fluctuating market conditions.
Top 10 Dividend Stocks In The United Kingdom
| Name | Dividend Yield | Dividend Rating |
| Treatt (LSE:TET) | 3.13% | ★★★★★☆ |
| Seplat Energy (LSE:SEPL) | 5.56% | ★★★★★☆ |
| RS Group (LSE:RS1) | 3.94% | ★★★★★☆ |
| Pets at Home Group (LSE:PETS) | 6.35% | ★★★★★★ |
| OSB Group (LSE:OSB) | 5.92% | ★★★★★☆ |
| NWF Group (AIM:NWF) | 4.73% | ★★★★★☆ |
| MONY Group (LSE:MONY) | 6.31% | ★★★★★★ |
| Keller Group (LSE:KLR) | 3.41% | ★★★★★☆ |
| IG Group Holdings (LSE:IGG) | 4.38% | ★★★★★☆ |
| 4imprint Group (LSE:FOUR) | 5.46% | ★★★★★★ |
Click here to see the full list of 50 stocks from our Top UK Dividend Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Helios Underwriting (AIM:HUW)
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Helios Underwriting plc, along with its subsidiaries, offers a limited liability investment opportunity for shareholders in the Lloyd’s insurance market in the UK, with a market cap of £161.68 million.
Operations: Helios Underwriting plc generates its revenue through investments in the Lloyd’s insurance market, providing shareholders with a limited liability opportunity in the UK.
Dividend Yield: 4.4%
Helios Underwriting has shown improvement in financial performance, with net income rising to £4.41 million for the half-year ended June 30, 2025. Despite a volatile dividend history and a yield of 4.42% which is below the UK market's top tier, its dividends are well covered by earnings and cash flows with payout ratios of 29.8% and 31.8%, respectively. The recent appointment of Louis Tucker as CEO may bring strategic leadership to stabilize dividends further.
- Unlock comprehensive insights into our analysis of Helios Underwriting stock in this dividend report.
- The valuation report we've compiled suggests that Helios Underwriting's current price could be quite moderate.
Multitude (LSE:0R4W)
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Multitude AG, with a market cap of €152.78 million, operates in Finland offering digital lending and online banking services through its subsidiaries.
Operations: Multitude AG generates revenue through its segments including SME Banking (€15.75 million), Consumer Banking (€114.14 million), and Wholesale Banking (€8.36 million).
Dividend Yield: 3.4%
Multitude AG's dividends have been volatile over the past decade, though recent earnings growth suggests potential stability. The company reported a significant rise in net income for the first half of 2025, reaching €14.16 million. Dividends are well covered by earnings and cash flows, with low payout ratios of 23.5% and 5.1%, respectively. Despite trading at a discount to its estimated fair value, its dividend yield of 3.38% remains below top UK payers.
- Click to explore a detailed breakdown of our findings in Multitude's dividend report.
- In light of our recent valuation report, it seems possible that Multitude is trading behind its estimated value.
Integrated Diagnostics Holdings (LSE:IDHC)
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Integrated Diagnostics Holdings plc is a consumer healthcare company offering medical diagnostics services to patients and has a market cap of $316.82 million.
Operations: Integrated Diagnostics Holdings plc generates its revenue from providing medical diagnostics services to patients.
Dividend Yield: 3.1%
Integrated Diagnostics Holdings has shown strong revenue growth, with sales reaching EGP 3.54 billion for the first half of 2025. Despite a volatile share price and an unstable dividend history, its dividends are well covered by earnings (46% payout ratio) and cash flows (40.8% payout ratio). The company trades at a significant discount to its estimated fair value but offers a lower dividend yield of 3.12% compared to top UK payers.
- Click here and access our complete dividend analysis report to understand the dynamics of Integrated Diagnostics Holdings.
- Our valuation report here indicates Integrated Diagnostics Holdings may be undervalued.
Taking Advantage
- Reveal the 50 hidden gems among our Top UK Dividend Stocks screener with a single click here.
- Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
- Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Interested In Other Possibilities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Integrated Diagnostics Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com